Drug-related problems vary with medication category and treatment duration in Taiwanese heart failure outpatients receiving case management

Journal of the Formosan Medical Association = Taiwan Yi Zhi
Wan-Tseng HsuChii-Ming Lee

Abstract

Heart failure (HF) patients are at high risk of having drug-related problems (DRPs). We aim to describe the frequency, types, and temporal occurrence of DRPs in Taiwanese HF outpatients receiving case management. In this study, we included 141 patients from HF clinics in three hospitals in Taiwan from October 2008 to December 2010. Nurse case managers at each of the participating sites registered case report forms (CRFs) for patients during clinic visits. DRPs were classified using the Pharmaceutical Care Network Europe Foundation (PCNE) classification system and documented by pharmacists after reviewing CRFs and participating in multidisciplinary team discussions. For 141 clinic participants, the average duration of medication use was 17 months, and 796 DRPs were reported. The DRPs most frequently recorded were the need for laboratory tests (32.7% of total DRPs), followed by potential interaction (29.6%), nonallergic side effects (13.3%), and insufficient awareness of health and disease (9.5%). The drugs most frequently causing a DRP were angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, diuretics, warfarin, spironolactone, and β-blockers. The incidence rates of total DRPs was maximal during the initia...Continue Reading

References

Oct 9, 1995·Archives of Internal Medicine·J A Johnson, J L Bootman
Jul 19, 2003·BMJ : British Medical Journal·Eike WrengerKlaus H Neumann
Aug 31, 2006·British Journal of Clinical Pharmacology·Kirsten K ViktilAasmund Reikvam
Oct 27, 2006·Pharmacy World & Science : PWS·Lotte Stig Haugbølle, Ellen Westh Sørensen
Mar 25, 2008·Therapeutics and Clinical Risk Management·Yvonne KohShu Chuen Li
Jul 25, 2009·Pharmacy World & Science : PWS·Bob W van Roozendaal, Ines Krass
Aug 9, 2011·Annual Review of Pharmacology and Toxicology·Jawed FareedDebra Hoppensteadt
Dec 15, 2012·Circulation·Alan S GoUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Apr 20, 2013·Current Cardiology Reviews·Yutao GuoAmitava Banerjee
Feb 18, 2014·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Ding-Cheng ChanShwu-Chong Wu

❮ Previous
Next ❯

Citations

Jan 18, 2018·International Journal of Clinical Pharmacy·Jiadan YangFeng Qiu
Aug 30, 2019·European Journal of Gastroenterology & Hepatology·Mina Aghili, Meera Neelathahalli Kasturirangan
Nov 11, 2019·International Journal of Clinical Pharmacy·Qin LiYun Liao
Jun 10, 2020·Journal of Clinical Pharmacy and Therapeutics·Xin WangLihong Liu
Oct 18, 2019·Journal of Pharmacy & Bioallied Sciences·Venkateswarlu KonuruGyadari Shravani
Apr 23, 2019·International Journal of Clinical Pharmacy·Elena M MifsudAnthony Serracino-Inglott
Nov 1, 2020·European Journal of Hospital Pharmacy. Science and Practice·Hui LiuSuishan Qiu
Jan 22, 2021·British Journal of Clinical Pharmacology·Xin WangLihong Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.